163 related articles for article (PubMed ID: 2899520)
1. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
[TBL] [Abstract][Full Text] [Related]
4. Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.
Cardellini M; Claudi F; Perlini V; Balduini W; Cattabeni F; Cimino M
Farmaco Sci; 1987 Apr; 42(4):307-17. PubMed ID: 3595841
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic activity and stereochemical considerations for rigid angular tricyclic congeners of dopamine: benzoquinoxalines and naphthothiazines.
Perrone R; Berardi F; Tortorella V; Racagni G; Rovescalli A
Farmaco; 1990 May; 45(5):479-88. PubMed ID: 2145846
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
7. Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands.
Claudi F; Cardellini M; Di Stefano A; Giorgioni G; Cantalamessa F; Renò F; Balduini W
Drug Des Discov; 1994 Feb; 11(2):115-25. PubMed ID: 7915549
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and dopamine receptor affinities of 2-(4-fluoro-3- hydroxyphenyl)ethylamine and N-substituted derivatives.
Claudi F; Cardellini M; Cingolani GM; Piergentili A; Peruzzi G; Balduini W
J Med Chem; 1990 Sep; 33(9):2408-12. PubMed ID: 1975274
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
Valchár M; Dobrovský K; Krejcí I; Dlabac A
Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
[No Abstract] [Full Text] [Related]
11. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
Hruska RE
J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
13. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
14. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Abbracchio MP; Paoletti AM; Balduini W
J Med Chem; 1992 Nov; 35(23):4408-14. PubMed ID: 1360027
[TBL] [Abstract][Full Text] [Related]
16. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
17. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
[TBL] [Abstract][Full Text] [Related]
18. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the relative hydrophobicity and interaction with striatal dopamine receptors in the bull of representative dialkylaminoalkyl and dialkylaminoacyl phenothiazine derivatives].
Brusova EG; Savel'eva MV
Biull Eksp Biol Med; 1988 Aug; 106(8):163-5. PubMed ID: 2901277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
